Soufflé Therapeutics

Soufflé Therapeutics Develops Targeted Gene Therapy for Autoimmune Diseases and Heart ConditionsSoufflé Therapeutics is developing a targeted gene therapy to treat autoimmune diseases and heart conditions. The company has built a platform for targeted tissue-specific gene therapy delivery by discovering new cellular proteins and pathways capable of delivering genetic payloads, enabling healthcare professionals to target macrophages and cardiomyocytes for the treatment of autoimmune diseases and heart conditions.